Alpha Tau Medical Ltd.

NasdaqCM:DRTS Stock Report

Market Cap: US$176.9m

Alpha Tau Medical Past Earnings Performance

Past criteria checks 0/6

Alpha Tau Medical's earnings have been declining at an average annual rate of -12.5%, while the Medical Equipment industry saw earnings growing at 12% annually.

Key information

-12.5%

Earnings growth rate

2.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equity-42.7%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?

May 25
Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?

Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Nov 08
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Alpha Tau director gives up board seat to take up chief commercial officer role

Sep 02

Alpha Tau Medical GAAP EPS of -$0.03

Aug 25

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Apr 12

Revenue & Expenses Breakdown

How Alpha Tau Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:DRTS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-30927
30 Jun 240-28927
31 Mar 240-29927
31 Dec 230-29926
30 Sep 230-25924
30 Jun 230-231022
31 Mar 230-161022
31 Dec 220-341121
30 Sep 220-34919
30 Jun 220-36717
31 Mar 220-41514
31 Dec 210-27211
30 Sep 210-26210
30 Jun 210-24210
31 Mar 210-1928
31 Dec 200-928

Quality Earnings: DRTS is currently unprofitable.

Growing Profit Margin: DRTS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DRTS is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.

Accelerating Growth: Unable to compare DRTS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DRTS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: DRTS has a negative Return on Equity (-42.71%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies